BioSpace News Archive

Inspired by the pandemic, Brain Navi developed a new robot to perform nasal swab tests autonomously to prevent cross infections so we can save the medical system and reestablish economies.

Takeda Pharmaceutical Company Limited announced financial results for the first quarter of fiscal year 2020.

Pfizer Inc. and BioNTech SE announced an agreement with the Ministry of Health, Labour and Welfare in Japan to supply 120 million doses of their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, subject to clinical success and regulatory approval, beginning in 2021.

111, Inc., a Company dedicated to digitally connecting patients with drugs and healthcare services in China, announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens on Thursday, August 20, 2020.

10 Clinical Posters and Video Presentations Highlight the Breadth of Clinical Benefits of the MolecuLight Device for Wound Care Practitioners

During July, Calliditas Therapeutics AB has issued 706,676 common shares as a result of the exercise of the over-allotment option within the initial public offering on The Nasdaq Global Select Market and the concurrent private placement of common shares to certain qualified investors in Europe and certain other jurisdictions outside of the United States.

Axovant Gene Therapies Ltd, a clinical-stage company developing innovative gene therapies for neurological diseases, announced that its subsidiary has signed a three-year Clinical Supply Agreement with Oxford Biomedica plc, a leading gene and cell therapy group.

Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic

Encouraging Data from FORWARD II Study of Mirvetuximab in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status, Presented at ASCO

Second-Quarter 2020 Worldwide Sales Were $10.9 Billion, a Decrease of 8%, Reflecting the Negative Impact of COVID-19; Excluding the Impact from Foreign Exchange, Sales Declined 5%